Author | Guiseppe Visani, MD | OncLive

Author | Guiseppe Visani, MD


Dr. Visani on Tosedostat and Cytarbine in Elderly Patients With AML

December 21, 2015


Guiseppe Visani, MD, director, Hematology and Stem Cell Transplant Center at AORMN, Pesaro, Italy, discusses a phase II study examining the efficacy of tosedostat plus low-dose cytarabine in elderly patients with acute myeloid leukemia.